Medipharm Labs Corp Stock Price on November 15, 2024
| LABS Stock | CAD 0.07 0.01 7.14% |
Below is the normalized historical share price chart for Medipharm Labs Corp extending back to February 14, 2018. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Medipharm Labs stands at 0.07, as last reported on the 28th of November, with the highest price reaching 0.07 and the lowest price hitting 0.07 during the day.
If you're considering investing in Medipharm Stock, it is important to understand the factors that can impact its price. As of now, Medipharm Stock is out of control. Medipharm Labs Corp has Sharpe Ratio of 0.0048, which conveys that the firm had a 0.0048% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Medipharm Labs, which you can use to evaluate the volatility of the firm. Please verify Medipharm Labs' Mean Deviation of 3.85, downside deviation of 7.71, and Risk Adjusted Performance of 0.0143 to check out if the risk estimate we provide is consistent with the expected return of 0.0259%.
At this time, Medipharm Labs' Total Stockholder Equity is very stable compared to the past year. As of the 28th of November 2024, Common Stock Shares Outstanding is likely to grow to about 381.5 M, while Other Stockholder Equity is likely to drop 0.00. . As of the 28th of November 2024, Price Earnings To Growth Ratio is likely to grow to 0.03, while Price To Sales Ratio is likely to drop 0.68. Medipharm Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
200 Day MA 0.0729 | 50 Day MA 0.0707 | Beta 0.921 |
Medipharm |
Sharpe Ratio = 0.0048
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | LABS |
Estimated Market Risk
| 5.41 actual daily | 48 52% of assets are more volatile |
Expected Return
| 0.03 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| 0.0 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Medipharm Labs is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Medipharm Labs by adding Medipharm Labs to a well-diversified portfolio.
Price Book 0.5932 | Enterprise Value Ebitda (1.82) | Price Sales 0.7078 | Shares Float 382.2 M | Wall Street Target Price 0.1 |
Medipharm Labs Valuation on November 15, 2024
It is possible to determine the worth of Medipharm Labs on a given historical date. On November 15, 2024 Medipharm was worth 0.07 at the beginning of the trading date compared to the closed value of 0.07. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Medipharm Labs stock. Still, in general, we apply an absolute valuation method to find Medipharm Labs' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Medipharm Labs where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Medipharm Labs' related companies.
| Open | High | Low | Close | Volume | |
| 0.07 | 0.07 | 0.07 | 0.07 | 733,709 | |
11/15/2024 | 0.07 | 0.07 | 0.07 | 0.07 | 143,313 |
| 0.07 | 0.07 | 0.07 | 0.07 | 48,400 |
| Backtest Medipharm Labs | | | Medipharm Labs History | | | Medipharm Labs Valuation | Previous | Next |
Medipharm Labs Trading Date Momentum on November 15, 2024
| On November 18 2024 Medipharm Labs Corp was traded for 0.07 at the closing time. The highest price during the trading period was 0.07 and the lowest recorded bid was listed for 0.07 . The volume for the day was 48.4 K. This history from November 18, 2024 did not cause price change. The trading delta at closing time to the current price is 0.00% . |
Medipharm Labs Corp Fundamentals Correlations and Trends
By evaluating Medipharm Labs' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Medipharm Labs' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Medipharm financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Medipharm Labs Stock history
Medipharm Labs investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Medipharm is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Medipharm Labs Corp will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Medipharm Labs stock prices may prove useful in developing a viable investing in Medipharm Labs
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 363.3 M | 381.5 M | |
| Net Loss | -27 M | -28.3 M |
Medipharm Labs Quarterly Net Working Capital |
|
Medipharm Labs Stock Technical Analysis
Medipharm Labs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Medipharm Labs Period Price Range
Low | November 28, 2024
| High |
0.00 | 0.00 |
Medipharm Labs Corp cannot be verified against its exchange. Please verify the symbol is currently traded on Toronto Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Medipharm Labs November 28, 2024 Market Strength
Market strength indicators help investors to evaluate how Medipharm Labs stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Medipharm Labs shares will generate the highest return on investment. By undertsting and applying Medipharm Labs stock market strength indicators, traders can identify Medipharm Labs Corp entry and exit signals to maximize returns
Medipharm Labs Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Medipharm Labs' price direction in advance. Along with the technical and fundamental analysis of Medipharm Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Medipharm to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0143 | |||
| Jensen Alpha | (0.10) | |||
| Total Risk Alpha | (0.81) | |||
| Sortino Ratio | (0.01) | |||
| Treynor Ratio | 0.0268 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Other Information on Investing in Medipharm Stock
Medipharm Labs financial ratios help investors to determine whether Medipharm Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medipharm with respect to the benefits of owning Medipharm Labs security.